AXDX logo

Accelerate Diagnostics (AXDX)

Profile

Full Name

Accelerate Diagnostics, Inc.

Ticker Symbol

AXDX

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

April 7, 1994

Indexes

Not included

Website

http://acceleratediagnostics.com

Employees

107

Key Details

Price

$0.56(-3.45%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$11.70M(-2.99% YoY)

Annual EPS

-$2.15(+56.48% YoY)

PE ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.56
AXDX price is $0.56

30-Day Relative Volume

1.67
AXDX 30-day relative volume is 1.67

Price Performance

Price Most recent change

-3.45%
AXDX price was down -3.45% on Apr 11, 2025

Price YTD change

-53.33%
AXDX price is down -53.33% since January 1st

Price 1-year change

-37.08%
AXDX price is down -37.08% year-on-year

Price 3-year change

-94.56%
AXDX price is down -94.56% over the past 3 years

Price Range

Price All-time high

$318.60
AXDX price is currently -99.82% below its historical high of $318.60

Price 3-year low

$0.49
AXDX price is currently +14.29% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$14.02M
AXDX market capitalization is $14.02 million

Market cap 3-year change

-80.18%
AXDX market capitalization is down -80.18% over the past 3 years

Market cap All-time high

$1.67B
AXDX market capitalization is currently -99.16% below its historical high of $1.67 billion

Market cap sector rank

24.57%
AXDX market capitalization is higher than 24.57% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+14.82%
AXDX shares outstanding is up +14.82% year-on-year

Shares Outstanding 3-Year Change

+264.47%
AXDX shares outstanding is up +264.47% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.31
AXDX beta is 0.31

200-day SMA

$1.39
AXDX price is currently -59.80% below its 200-day simple moving average

50-day SMA

$1.03
AXDX price is currently -45.55% below its 50-day simple moving average

RSI

19.53
AXDX 14-day relative strength index is 19.53

Volume

1.67
AXDX 30-day relative volume is 1.67

ATR

$0.09
AXDX average true range is $0.09

10-day Historical Volatility

54.62%
AXDX 10-day historical volatility is 54.62%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$11.70M
AXDX annual revenue is $11.70 million

Revenue Analysts estimate

$12.30M
AXDX annual revenue is currently -4.89% lower than the consensus analysts' forecast

Revenue 1-year change

-2.99%
AXDX annual revenue is down -2.99% year-on-year

Revenue Sector rank

30.35%
AXDX annual revenue is higher than 30.35% of companies in Healthcare sector

EPS

EPS

-$2.15
AXDX annual earnings per share is -$2.15

EPS Analysts estimate

-
AXDX annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+56.48%
AXDX annual earnings per share is up +56.48% year-on-year

EPS Sector rank

37.24%
AXDX annual earnings per share is higher than 37.24% of companies in Healthcare sector

Profit

Gross profit

$2.70M
AXDX annual gross profit is $2.70 million

Gross margin

23.12%
AXDX annual gross profit margin is 23.12%

Operating profit

-$35.31M
AXDX annual operating income is -$35.31 million

Operating margin

-301.85%
AXDX annual operating profit margin is -301.85%

Net income

-$50.05M
AXDX annual net profit is -$50.05 million

Net margin

-427.81%
AXDX annual net profit margin is -427.81%

Expenses

Total expenses

$47.01M
AXDX annual total expenses is $47.01 million

Operating expenses

$38.01M
AXDX annual total operating expenses is $38.01 million

Cost of goods sold

$8.99M
AXDX annual cost of goods sold is $8.99 million

Selling, general & administrative expenses

$21.33M
AXDX annual SGA is $21.33 million

Depreciation and amortization

$3.42M
AXDX annual depreciation & amortization is $3.42 million

Interest expense

$13.12M
AXDX annual interest expense is $13.12 million

Income tax

-$66.00K
AXDX annual income tax is -$66.00 thousand

EBIT & EBITDA

EBIT

-$36.99M
AXDX annual earnings before interest & taxes is -$36.99 million

EBITDA

-$33.57M
AXDX annual EBITDA is -$33.57 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$28.56M
AXDX annual total assets is $28.56 million

Non current assets

$6.32M
AXDX annual long term assets is $6.32 million

Current assets

$22.24M
AXDX annual total current assets is $22.24 million

Cash and cash equivalents

$15.10M
AXDX annual cash & cash equivalents is $15.10 million

Accounts receivable

$2.04M
AXDX annual accounts receivable is $2.04 million

Inventory

$2.85M
AXDX annual inventory is $2.85 million

Liabilities

Total liabilities

$84.60M
AXDX annual total liabilities is $84.60 million

Long term liabilities

$53.40M
AXDX annual total long term liabilities is $53.40 million

Current liabilities

$31.20M
AXDX annual total current liabilities is $31.20 million

Accounts payable

$4.84M
AXDX annual accounts payable is $4.84 million

Debt

Total debt

$66.58M
AXDX annual total debt is $66.58 million

Total debt 1-year change

+69.75%
AXDX annual total debt is up +69.75% year-on-year

Long term debt

$49.44M
AXDX annual long term debt is $49.44 million

Short term debt

$17.14M
AXDX annual short term debt is $17.14 million

Equity & Capital

Shareholders equity

-$56.04M
AXDX annual stockholders equity is -$56.04 million

Book value

-$56.04M
AXDX annual book value is -$56.04 million

Retained earnings

-$718.90M
AXDX annual retained earnings is -$718.90 million

Working capital

-$8.96M
AXDX annual working capital is -$8.96 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$24.19M
AXDX annual cash flow from operations is -$24.19 million

Cash from operations 1-year change

+39.81%
AXDX annual cash flow from operations is up +39.81% year-on-year

Cash from investing

-$509.00K
AXDX annual cash flow from investing activities is -$509.00 thousand

Cash from investing 1-year change

-105.88%
AXDX annual cash flow from investing activities is down -105.88% year-on-year

Cash from financing

$27.05M
AXDX annual cash flow from financing activities is $27.05 million

Cash from financing 1-year change

+199.96%
AXDX annual cash flow from financing activities is up +199.96% year-on-year

CAPEX

CAPEX

$509.00K
AXDX annual capital expenditures is $509.00 thousand

CAPEX 1-year change

-50.82%
AXDX annual capital expenditures is down -50.82% year-on-year

Free Cash Flow

Free cash flow

-$24.70M
AXDX annual free cash flow is -$24.70 million

Free cash flow 1-year change

+40.09%
AXDX annual free cash flow is up +40.09% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

23.12%
AXDX annual gross profit margin is 23.12%

Operating margin

-301.85%
AXDX annual operating profit margin is -301.85%

Net margin

-427.81%
AXDX annual net profit margin is -427.81%

ROA & ROE

ROA

-167.03%
AXDX annual return on assets is -167.03%

ROE

89.30%
AXDX annual return on equity is 89.30%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
AXDX price to earnings ratio value is unknown

PE ratio Sector rank

-
AXDX price to earnings ratio is unknown

PB Ratio

PB ratio

-0.25
AXDX price to book ratio is -0.25

PB ratio Sector rank

11.51%
AXDX price to book ratio is higher than 11.51% of companies in Healthcare sector

PS Ratio

PS ratio

1.20
AXDX price to sales ratio is 1.20

PS ratio Sector rank

31.15%
AXDX price to sales ratio is higher than 31.15% of companies in Healthcare sector

Enterprise value

Enterprise value

$65.50M
AXDX enterprise value is $65.50 million

Enterprise value Sector rank

45%
AXDX enterprise value is higher than 45% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.95
AXDX EV/EBITDA is -1.95

EV/EBITDA Sector rank

31.71%
AXDX EV/EBITDA is higher than 31.71% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.71
AXDX annual current ratio is 0.71

Quick ratio

0.62
AXDX annual quick ratio is 0.62

Leverage

Debt to equity

-1.13
AXDX annual debt to equity ratio is -1.13

Interest coverage ratio

-2.82
AXDX annual interest coverage ratio is -2.82

Risk & Stability

Piotroski F-Score

2
AXDX piotroski f-score is 2

Altman Z-Score

-39.39
AXDX altman z-score is -39.39

Analyst ratings

Recent major analysts updates

Apr 1, 24 Craig-Hallum
Hold
Mar 9, 22 Craig-Hallum
Hold
Oct 8, 20 BTIG
Neutral
Aug 10, 20 Piper Sandler
Overweight
Sep 27, 19 JP Morgan
Underweight
Nov 7, 18 JP Morgan
Neutral
May 24, 18 Craig-Hallum
Hold
Dec 19, 17 BTIG Research
Neutral
Dec 13, 17 BTIG
Neutral
Aug 9, 16 JP Morgan
Overweight

Institutional Ownership

Similar stocks

CLDI logo
Calidi Biotherapeutics (CLDI)
PRTG logo
Portage Biotech (PRTG)
CING logo
Cingulate (CING)
Abpro (ABP)
MIRA logo
MIRA Pharmaceuticals (MIRA)
VVOS logo
Vivos Therapeutics (VVOS)
BIVI logo
BioVie (BIVI)
BNGO logo
Bionano Genomics (BNGO)
ALUR logo
Allurion Technologies (ALUR)
  • What is the ticker symbol for Accelerate Diagnostics?
  • Does Accelerate Diagnostics pay dividends?
  • What sector is Accelerate Diagnostics in?
  • What industry is Accelerate Diagnostics in?
  • What country is Accelerate Diagnostics based in?
  • When did Accelerate Diagnostics go public?
  • Is Accelerate Diagnostics in the S&P 500?
  • Is Accelerate Diagnostics in the NASDAQ 100?
  • Is Accelerate Diagnostics in the Dow Jones?
  • When was Accelerate Diagnostics's last earnings report?
  • When does Accelerate Diagnostics report earnings?
  • Should I buy Accelerate Diagnostics stock now?

What is the ticker symbol for Accelerate Diagnostics?

The ticker symbol for Accelerate Diagnostics is NASDAQ:AXDX

Does Accelerate Diagnostics pay dividends?

No, Accelerate Diagnostics does not pay dividends

What sector is Accelerate Diagnostics in?

Accelerate Diagnostics is in the Healthcare sector

What industry is Accelerate Diagnostics in?

Accelerate Diagnostics is in the Medical Devices industry

What country is Accelerate Diagnostics based in?

Accelerate Diagnostics is headquartered in United States

When did Accelerate Diagnostics go public?

Accelerate Diagnostics's initial public offering (IPO) was on April 7, 1994

Is Accelerate Diagnostics in the S&P 500?

No, Accelerate Diagnostics is not included in the S&P 500 index

Is Accelerate Diagnostics in the NASDAQ 100?

No, Accelerate Diagnostics is not included in the NASDAQ 100 index

Is Accelerate Diagnostics in the Dow Jones?

No, Accelerate Diagnostics is not included in the Dow Jones index

When was Accelerate Diagnostics's last earnings report?

Accelerate Diagnostics's most recent earnings report was on Mar 21, 2025

When does Accelerate Diagnostics report earnings?

The next expected earnings date for Accelerate Diagnostics is May 8, 2025

Should I buy Accelerate Diagnostics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page